Fund profile
Tickers
BBP
Fund manager
Total assets
$17.74 mm
Liabilities
$523.65 k
Net assets
$17.22 mm
Number of holdings
55.00
BBP stock data
55 Holdings
Security | $Holding | Balance | % of Fund | Category | Position | Country |
---|---|---|---|---|---|---|
DREYFUS GOVERNMENT CASH MANAGE | 501.84 k | 501.84 k shares | 2.91 | Short-term investment vehicle | Long | USA |
LXRX Lexicon Pharmaceuticals Inc | 469.23 k | 250.92 k shares | 2.73 | Common equity | Long | USA |
TARS Tarsus Pharmaceuticals Inc | 464.74 k | 17.06 k shares | 2.70 | Common equity | Long | USA |
ADMA Adma Biologics Inc | 419.06 k | 80.74 k shares | 2.43 | Common equity | Long | USA |
SWTX SpringWorks Therapeutics Inc | 415.09 k | 9.41 k shares | 2.41 | Common equity | Long | USA |
SRPT Sarepta Therapeutics Inc | 410.63 k | 3.45 k shares | 2.38 | Common equity | Long | USA |
IRWD Ironwood Pharmaceuticals Inc - Ordinary Shares | 404.26 k | 28.49 k shares | 2.35 | Common equity | Long | USA |
AXSM Axsome Therapeutics Inc | 400.81 k | 4.45 k shares | 2.33 | Common equity | Long | USA |
APLS Apellis Pharmaceuticals Inc | 395.63 k | 6.25 k shares | 2.30 | Common equity | Long | USA |
SAGE Sage Therapeutics Inc | 394.34 k | 15.38 k shares | 2.29 | Common equity | Long | USA |
MRNA Moderna Inc | 383.89 k | 3.80 k shares | 2.23 | Common equity | Long | USA |
NBIX Neurocrine Biosciences, Inc. | 375.70 k | 2.69 k shares | 2.18 | Common equity | Long | USA |
AMGN AMGEN Inc. | 371.14 k | 1.18 k shares | 2.16 | Common equity | Long | USA |
IMCR Immunocore Holdings plc | 368.97 k | 5.10 k shares | 2.14 | Common equity | Long | UK |
AMLX Amylyx Pharmaceuticals Inc | 354.08 k | 22.13 k shares | 2.06 | Common equity | Long | USA |
ASND Ascendis Pharma A/S | 352.89 k | 2.72 k shares | 2.05 | Common equity | Long | Denmark |
LGND Ligand Pharmaceuticals, Inc. - Ordinary Shares | 352.20 k | 4.82 k shares | 2.05 | Common equity | Long | USA |
REGN Regeneron Pharmaceuticals, Inc. | 350.71 k | 372.00 shares | 2.04 | Common equity | Long | USA |
VRTX Vertex Pharmaceuticals, Inc. | 347.57 k | 802.00 shares | 2.02 | Common equity | Long | USA |
TVTX Travere Therapeutics Inc | 337.54 k | 37.80 k shares | 1.96 | Common equity | Long | USA |
KNSA Kiniksa Pharmaceuticals Ltd - Ordinary Shares | 337.30 k | 19.13 k shares | 1.96 | Common equity | Long | USA |
IONS Ionis Pharmaceuticals Inc | 336.50 k | 6.55 k shares | 1.95 | Common equity | Long | USA |
ITCI Intra-Cellular Therapies Inc | 336.30 k | 4.99 k shares | 1.95 | Common equity | Long | USA |
RYTM Rhythm Pharmaceuticals Inc. | 335.10 k | 7.60 k shares | 1.95 | Common equity | Long | USA |
CRSP CRISPR Therapeutics AG | 326.27 k | 5.18 k shares | 1.89 | Common equity | Long | Switzerland |
FOLD Amicus Therapeutics Inc | 325.68 k | 26.20 k shares | 1.89 | Common equity | Long | USA |
AGIO Agios Pharmaceuticals Inc | 317.49 k | 14.04 k shares | 1.84 | Common equity | Long | USA |
INSM Insmed Inc | 314.00 k | 11.30 k shares | 1.82 | Common equity | Long | USA |
BIIB Biogen Inc | 313.75 k | 1.27 k shares | 1.82 | Common equity | Long | USA |
RARE Ultragenyx Pharmaceutical Inc. | 313.40 k | 7.11 k shares | 1.82 | Common equity | Long | USA |
GILD Gilead Sciences, Inc. | 312.18 k | 3.99 k shares | 1.81 | Common equity | Long | USA |
BBIO BridgeBio Pharma Inc | 311.49 k | 9.08 k shares | 1.81 | Common equity | Long | USA |
BPMC Blueprint Medicines Corp | 309.53 k | 3.89 k shares | 1.80 | Common equity | Long | USA |
PTCT PTC Therapeutics Inc | 308.36 k | 11.82 k shares | 1.79 | Common equity | Long | USA |
HRMY Harmony Biosciences Holdings Inc | 304.58 k | 9.66 k shares | 1.77 | Common equity | Long | USA |
EXEL Exelixis Inc | 304.51 k | 13.99 k shares | 1.77 | Common equity | Long | USA |
ALNY Alnylam Pharmaceuticals Inc | 302.42 k | 1.75 k shares | 1.76 | Common equity | Long | USA |
ACAD Acadia Pharmaceuticals Inc | 301.20 k | 11.63 k shares | 1.75 | Common equity | Long | USA |
INCY Incyte Corp. | 300.31 k | 5.11 k shares | 1.74 | Common equity | Long | USA |
BNTX BioNTech SE | 298.24 k | 3.14 k shares | 1.73 | Common equity | Long | Germany |
DCPH Deciphera Pharmaceuticals Inc | 295.08 k | 20.61 k shares | 1.71 | Common equity | Long | USA |
BMRN Biomarin Pharmaceutical Inc. - Registered Shares | 294.36 k | 3.34 k shares | 1.71 | Common equity | Long | USA |
ROIV Roivant Sciences Ltd | 293.08 k | 29.31 k shares | 1.70 | Common equity | Long | USA |
LEGN Legend Biotech Corp | 292.59 k | 5.31 k shares | 1.70 | Common equity | Long | USA |
TBPH Theravance Biopharma Inc | 280.87 k | 29.63 k shares | 1.63 | Common equity | Long | Cayman Islands |
HALO Halozyme Therapeutics Inc. | 279.91 k | 8.27 k shares | 1.63 | Common equity | Long | USA |
UTHR United Therapeutics Corp | 275.78 k | 1.28 k shares | 1.60 | Common equity | Long | USA |
AUPH Aurinia Pharmaceuticals Inc | 272.37 k | 36.12 k shares | 1.58 | Common equity | Long | Canada |
BCRX Biocryst Pharmaceuticals Inc. | 268.87 k | 50.73 k shares | 1.56 | Common equity | Long | USA |
BGNE BeiGene Ltd | 257.77 k | 1.74 k shares | 1.50 | Common equity | Long | USA |
MIRM Mirum Pharmaceuticals Inc | 249.52 k | 9.43 k shares | 1.45 | Common equity | Long | USA |
ZLAB Zai Lab Limited | 232.91 k | 10.80 k shares | 1.35 | Common equity | Long | China |
BLUE Bluebird bio Inc | 100.83 k | 98.85 k shares | 0.59 | Common equity | Long | USA |
OABI OmniAb Inc | 0 | 1.30 k shares | 0.00 | Common equity | Long | USA |
OABI OmniAb Inc | 0 | 1.30 k shares | 0.00 | Common equity | Long | USA |